OSI SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OSI SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $1.09B | Aug 28, 2018 |
| FY2018 | Jun 30, 2017 | $960.95M | Aug 28, 2018 |
| FY2018 | Jun 30, 2016 | $829.66M | Aug 28, 2018 |
| FY2017 | Jun 30, 2015 | $958.20M | Sep 7, 2017 |
| FY2016 | Jun 30, 2014 | $906.74M | Aug 19, 2016 |
| FY2015 | Jun 30, 2013 | $802.05M | Aug 24, 2015 |
| FY2014 | Jun 30, 2012 | $792.99M | Aug 27, 2014 |
| FY2013 | Jun 30, 2011 | $656.10M | Aug 16, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jun 30, 2013 | $802.05M | Aug 16, 2013 |
| FY2012 | Jun 30, 2012 | $792.99M | Aug 13, 2012 |
| FY2012 | Jun 30, 2011 | $656.10M | Aug 13, 2012 |
| FY2012 | Jun 30, 2010 | $595.11M | Aug 13, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $168.24M | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | $150.29M | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | $147.15M | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | $121.50M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $154.32M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $136.10M | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | $141.30M | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | $98.75M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $143.02M | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | $103.79M | Aug 29, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $52.75M | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | $41.13M | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | $37.82M | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | $17.94M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $44.68M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $34.04M | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | $36.55M | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | $12.88M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $91.78M | Aug 25, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $73.02M | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | $56.22M | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | $57.96M | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | $30.33M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $62.82M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $51.36M | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | $52.32M | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | $22.56M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $57.15M | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | $34.34M | Aug 29, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $18.84M | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | $18.57M | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | $18.26M | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | $17.77M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $15.86M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $17.14M | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | $16.35M | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | $15.92M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $15.50M | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | $14.85M | Aug 29, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $74.69M | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | $73.25M | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | $70.72M | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | $72.22M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $71.75M | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | $66.58M | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | $71.60M | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | $59.80M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $67.17M | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | $53.71M | Aug 29, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $97.59M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | ($87.50M) | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $94.81M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $63.81M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $139.07M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $129.18M | Aug 19, 2022 |
| FY2021 | Jun 30, 2019 | $119.11M | Aug 23, 2021 |
| FY2020 | Jun 30, 2018 | $133.11M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $62.78M | Aug 27, 2019 |
| FY2018 | Jun 30, 2016 | $59.22M | Aug 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $23.83M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $22.10M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $15.81M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $14.92M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $16.90M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $21.06M | Aug 19, 2022 |
| FY2021 | Jun 30, 2019 | $27.41M | Aug 23, 2021 |
| FY2020 | Jun 30, 2018 | $43.20M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $17.10M | Aug 27, 2019 |
| FY2018 | Jun 30, 2016 | $17.69M | Aug 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.24B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $1.94B | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $1.56B | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $1.44B | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $1.38B | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $1.27B | Aug 19, 2022 |
| FY2021 | Jun 30, 2019 | $1.26B | Aug 23, 2021 |
| FY2020 | Jun 30, 2018 | $1.26B | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $1.23B | Aug 27, 2019 |
| FY2018 | Jun 30, 2016 | $991.72M | Aug 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.29B | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $1.07B | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $829.52M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $804.73M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $744.55M | Aug 19, 2022 |
| FY2021 | Jun 30, 2020 | $696.39M | Aug 23, 2021 |
| FY2020 | Jun 30, 2019 | $713.14M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $766.26M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $660.87M | Aug 28, 2018 |
| FY2017 | Jun 30, 2016 | $450.88M | Sep 7, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $951.08M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $863.48M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $726.17M | Aug 25, 2025 |
| FY2025 | Jun 30, 2022 | $638.42M | Aug 25, 2025 |
| FY2024 | Jun 30, 2021 | $639.82M | Aug 29, 2024 |
| FY2023 | Jun 30, 2020 | $572.15M | Aug 29, 2023 |
| FY2022 | Jun 30, 2019 | $551.73M | Aug 19, 2022 |
| FY2021 | Jun 30, 2018 | $489.44M | Aug 23, 2021 |
| FY2020 | Jun 30, 2017 | $569.21M | Aug 21, 2020 |
| FY2019 | Jun 30, 2016 | $540.85M | Aug 27, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $387.39M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $351.48M | Aug 25, 2025 |
| FY2025 | Jun 30, 2023 | $349.51M | Aug 25, 2025 |
| FY2024 | Jun 30, 2022 | $336.36M | Aug 29, 2024 |
| FY2023 | Jun 30, 2021 | $320.30M | Aug 29, 2023 |
| FY2022 | Jun 30, 2020 | $310.63M | Aug 19, 2022 |
| FY2021 | Jun 30, 2019 | $307.11M | Aug 23, 2021 |
| FY2020 | Jun 30, 2018 | $292.21M | Aug 21, 2020 |
| FY2019 | Jun 30, 2017 | $242.13M | Aug 27, 2019 |
| FY2018 | Jun 30, 2016 | $122.82M | Aug 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $942.25M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $861.23M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $735.96M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $663.87M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $548.84M | Aug 19, 2022 |
| FY2021 | Jun 30, 2020 | $474.79M | Aug 23, 2021 |
| FY2020 | Jun 30, 2019 | $399.54M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $334.75M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $363.87M | Aug 28, 2018 |
| FY2017 | Jun 30, 2016 | $338.99M | Sep 7, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $106.41M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | $95.35M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | $76.75M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | $64.20M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | $80.61M | Aug 19, 2022 |
| FY2021 | Jun 30, 2020 | $76.10M | Aug 23, 2021 |
| FY2020 | Jun 30, 2019 | $96.32M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $84.81M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | $169.65M | Aug 28, 2018 |
| FY2017 | Jun 30, 2016 | $104.37M | Sep 7, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $471.63M | Aug 25, 2025 |
| FY2024 | Jun 30, 2024 | $137.55M | Aug 29, 2024 |
| FY2023 | Jun 30, 2023 | $144.57M | Aug 29, 2023 |
| FY2022 | Jun 30, 2022 | $293.44M | Aug 19, 2022 |
| FY2021 | Jun 30, 2021 | $277.27M | Aug 23, 2021 |
| FY2020 | Jun 30, 2020 | $268.00M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | $289.56M | Aug 27, 2019 |
| FY2017 | Jun 30, 2017 | $244.15M | Sep 7, 2017 |
| FY2017 | Jun 30, 2016 | $8.81M | Sep 7, 2017 |
| FY2016 | Jun 30, 2015 | $11.36M | Aug 19, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 3 | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | 2 | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | 2 | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 2 | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | 2 | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | 2 | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | 2 | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | 1 | Aug 29, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 3 | Aug 25, 2025 |
| FY2025 | Mar 31, 2025 | 2 | Aug 25, 2025 |
| FY2025 | Dec 31, 2024 | 2 | Aug 25, 2025 |
| FY2025 | Sep 30, 2024 | 1 | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 2 | Aug 25, 2025 |
| FY2025 | Mar 31, 2024 | 1 | Aug 25, 2025 |
| FY2025 | Dec 31, 2023 | 2 | Aug 25, 2025 |
| FY2025 | Sep 30, 2023 | 0 | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | 2 | Aug 29, 2024 |
| FY2024 | Mar 31, 2023 | 1 | Aug 29, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 16.79M | Aug 25, 2025 |
| FY2025 | Jun 30, 2024 | 17.06M | Aug 25, 2025 |
| FY2024 | Jun 30, 2023 | 16.76M | Aug 29, 2024 |
| FY2023 | Jun 30, 2022 | 16.87M | Aug 29, 2023 |
| FY2022 | Jun 30, 2021 | 17.85M | Aug 19, 2022 |
| FY2021 | Jun 30, 2020 | 18.01M | Aug 23, 2021 |
| FY2020 | Jun 30, 2019 | 18.17M | Aug 21, 2020 |
| FY2019 | Jun 30, 2018 | 18.03M | Aug 27, 2019 |
| FY2018 | Jun 30, 2017 | 18.69M | Aug 28, 2018 |
| FY2017 | Jun 30, 2016 | 18.91M | Sep 7, 2017 |